After stratification by cigarette smoking status, the association between NAT2 slow acetylation genotype and bladder cancer risk was stronger but not statistically significant among ever smokers (OR = 1.76; 95% CI, 0.88–3.52) (p for interaction = 0.15). This evidence concerns the gene NAT2 and urinary bladder cancer.